Palmitoleic acid (N-7) attenuates the immunometabolic disturbances caused by a high-fat diet independently of ppar α

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Souza, Camila O ^a   Teixeira, Alexandre A S ^a   Lima, Edson A ^a   Batatinha, Helena A P ^a   Gomes, Lara M ^b   Carvalho Silva, Milena ^b   Mota, Isabella T ^b   Streck, Emilio L ^b   Hirabara, Sandro M ^c   Neto, José C Rosa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^c UNIVERSIDADE CRUZEIRO DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; INSULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 8; MALATE DEHYDROGENASE; OLEIC ACID; PALMITOLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SUCCINATE DEHYDROGENASE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; MONOUNSATURATED FATTY ACID; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BROWN ADIPOSE TISSUE; CHOLESTEROL BLOOD LEVEL; CITRIC ACID CYCLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HEPATITIS; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN TOLERANCE TEST; LIPID DIET; MOUSE; NONHUMAN; OBESITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLEUS MUSCLE; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WESTERN BLOTTING; ADVERSE EVENT; ANIMAL; C57BL MOUSE; DRUG EFFECT; GENETICS; KNOCKOUT MOUSE; LIVER; MALE; METABOLISM;

ANIMALS; BLOTTING, WESTERN; DIET, HIGH-FAT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, MONOUNSATURATED; INSULIN RESISTANCE; INTERLEUKIN-12; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLEIC ACID; PPAR ALPHA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929112616     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/582197     Document Type: Article

References (51)

1. S. Zelber-Sagi, D. Nitzan-Kaluski, Z. Halpern, and R. Oren, "Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures, " Liver International, vol. 26, no. 7, pp. 856-863, 2006.
2. G. S. Hotamisligil and E. Erbay, "Nutrient sensing and inflammation in metabolic diseases, " Nature Reviews Immunology, vol. 8, no. 12, pp. 923-934, 2008.
3. Y. C. Wang, K. McPherson, T. Marsh, S. L. Gortmaker, and M. Brown, "Health and economic burden of the projected obesity trends in the USA and the UK, " The Lancet, vol. 378, no. 9793, pp. 815-825, 2011.
4. K. Makki, P. Froguel, and I. Wolowczuk, "Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines, " ISRN Inflammation, vol. 2013, Article ID 139239, 12 pages, 2013.
5. K. Singer, D. S. Eng, C. N. Lumeng, A. Gebremariam, and J. M. Lee, "The relationship between body fat mass percentiles and inflammation in children, " Obesity, vol. 22, no. 5, pp. 1332-1336, 2014.
6. L. Chen, D. J. Magliano, and P. Z. Zimmet, "The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives, " Nature Reviews Endocrinology, vol. 8, no. 4, pp. 228-236, 2012.
7. B. Q. Starley, C. J. Calcagno, and S. A. Harrison, "Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection, " Hepatology, vol. 51, no. 5, pp. 1820-1832, 2010.
8. L. M. Pawella, M. Hashani, E. Eiteneuer et al. , "Perilipin discerns chronic from acute hepatocellular steatosis, " Journal of Hepatology, vol. 60, pp. 633-642, 2014.
9. X. Leverve, "Hyperglycemia and oxidative stress: complex relationshipswith attractive prospects, " IntensiveCareMedicine, vol. 29, no. 4, pp. 511-514, 2003.
10. M. Sanz, C. Sanchez-Martin, D. Detaille et al. , "Acutemitochondrial actions of glitazones on the liver: a crucial parameter for their antidiabetic properties, " Cellular Physiology and Biochemistry, vol. 28, no. 5, pp. 899-910, 2011.
11. H. Cao, K. Gerhold, J. R. Mayers, M. M. Wiest, S. M. Watkins, and G. S. Hotamisligil, "Identification of a lipokine , a lipid hormone linking adipose tissue to systemic metabolism, " Cell, vol. 134, no. 6, pp. 933-944, 2008.
12. X. Guo, H. Li, H. Xu et al. , "Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice, " PLoS ONE, vol. 7, no. 6, Article ID e39286, 2012.
13. Z. H. Yang, H. Miyahara, and A. Hatanaka, "Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay mice with genetic type 2 diabetes, " Lipids in Health and Disease, vol. 10, article 120, 2011.
14. A. Bolsoni-Lopes, W. T. Festuccia, T. S. Farias et al. , "Palmitoleic acid (n-7) increases white adipocyte lipolysis and lipase content in a PPARα-dependent manner, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 305, no. 9, pp. E1093-E1102, 2013.
15. M. Cherkaoui-Malki, S. Surapureddi, H. I. El Hajj, J. Vamecq, and P. Andreoletti, "Hepatic steatosis and peroxisomal fatty acid beta-oxidation, " Current Drug Metabolism, vol. 13, no. 10, pp. 1412-1421, 2012.
16. R. A. Daynes and D. C. Jones, "Emerging roles of PPARs in inflammation and immunity, " Nature Reviews Immunology, vol. 2, no. 10, pp. 748-759, 2002.
17. P. G. Reeves, F. H. Nielsen, and G. C. Fahey Jr. , "AIN-93 purified diets for laboratory rodents: final report of the American Institute ofNutrition ad hocwriting committee on the reformulation of the AIN-76A rodent diet, " Journal of Nutrition, vol. 123, no. 11, pp. 1939-1951, 1993.
18. P. Srisawasdi, S. Chaloeysup, Y. Teerajetgul et al. , "Estimation of plasma small dense LDL cholesterol from classic lipid measures, " American Journal of Clinical Pathology, vol. 136, no. 1, pp. 20-29, 2011.
19. Y. Yin, Z. Yu, M. Xia, X. Luo, X. Lu, and W. Ling, "Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism, " European Journal of Clinical Investigation, vol. 42, no. 11, pp. 1189-1196, 2012.
20. J. Folch, M. Lees, and G. H. Sloane Stanley, "A simple method for the isolation and purification of total lipides from animal tissues, " The Journal of Biological Chemistry, vol. 226, no. 1, pp. 497-509, 1957.
21. E. Bonora, P. Moghetti, C. Zancanaro et al. , "Estimates of in vivo insulinaction inman: comparisonof insulintolerance testswith euglycemic and hyperglycemic glucose clamp studies, " Journal of Clinical Endocrinology andMetabolism, vol. 68, no. 2, pp. 374-378, 1989.
22. H. Bergmeyer and E. Bernet, "Determination of glucose with glucoseoxidase and peroxidase, " inMethods of Enzymatic Analysis, H. Bergmeyer, Ed. , pp. 1205-1215, Academic Press, New York, NY, USA, 1974.
23. R. A. J. Challiss, F. J. Lozeman, B. Leighton, and E. A. Newsholme, "Effects of the β-adrenoceptor agonist isoprenaline on insulin-sensitivity in soleus muscle of the rat, " Biochemical Journal, vol. 233, no. 2, pp. 377-381, 1986.
24. J. Espinal, G. L. Dohm, and E. A. Newsholme, "Sensitivity to insulin of glycolysis and glycogen synthesis of isolated soleusmuscle strips from sedentary, exercised and exercise-trained rats, " Biochemical Journal, vol. 212, no. 2, pp. 453-458, 1983.
25. B. Leighton, L. Budohoski, F. J. Lozeman, R. A. Challiss, and E. A. Newsholme, "The effect of prostaglandins E1, E2 and F2 alpha and indomethacin on the sensitivity of glycolysis and glycogen synthesis to insulin in stripped soleus muscles of the rat, " The Biochemical journal, vol. 227, no. 1, pp. 337-340, 1985.
26. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, "Protein measurement with the folin phenol reagent, " The Journal of biological chemistry, vol. 193, no. 1, pp. 265-275, 1951.
27. P. A. Srere, "Controls of citrate synthase activity, " Life Sciences, vol. 15, no. 10, pp. 1695-1710, 1974.
28. J. C. Fischer, W. Ruitenbeek, J. A. Berden et al. , "Differential investigation of the capacity of succinate oxidation in human skeletal muscle, " Clinica Chimica Acta, vol. 153, no. 1, pp. 23-36, 1985.
29. G. B. Kitto, P. M. Wassarman, and N. O. Kaplan, "Enzymatically active conformers of mitochondrial malate dehydrogenase, " Proceedings of the National Academy of Sciences of the United States of America, vol. 56, no. 2, pp. 578-585, 1966.
30. A. Cassina and R. Radi, "Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport, " Archives of Biochemistry and Biophysics, vol. 328, no. 2, pp. 309-316, 1996.
31. P. Chomczynski and N. Sacchi, "Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, " Analytical Biochemistry, vol. 162, no. 1, pp. 156-159, 1987.
32. K. J. Livak and T. D. Schmittgen, "Analysis of relative gene expression data using real-time quantitative PCR and the 2-δδ Tmethod, " Methods, vol. 25, no. 4, pp. 402-408, 2001.
33. S. Mandard, M. Muller, and S. Kersten, "Peroxisome proliferator-activated receptor α target genes, " Cellular and Molecular Life Sciences, vol. 61, no. 4, pp. 393-416, 2004.
34. R. Stienstra, S. Mandard, D. Patsouris, C. Maass, S. Kersten, and M. Muller, "Peroxisome proliferator-activated receptor α protects against obesity-induced hepatic inflammation, " Endocrinology, vol. 148, no. 6, pp. 2753-2763, 2007.
35. F. A. Monsalve, R. D. Pyarasani, F. Delgado-Lopez, and R. Moore-Carrasco, "Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases, " Mediators of Inflammation, vol. 2013, Article ID 549627, 18 pages, 2013.
36. E. Ip, G. Farrell, P. Hall, G. Robertson, and I. Leclercq, "Administration of the potent pparα agonist, Wy-14, 643, reverses nutritional fibrosis and steatohepatitis in mice, " Hepatology, vol. 39, no. 5, pp. 1286-1296, 2004.
37. G. Tapia, R. Valenzuela, A. Espinosa et al. , "N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-αB DNA binding abrogation, " Molecular Nutrition and Food Research, vol. 58, no. 6, pp. 1333-1341, 2014.
38. P. Quintero and M. Arrese, "Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis : therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism, " Hepatology, vol. 58, pp. 1881-1884, 2013.
39. T. Hashimoto, T. Fujita, N. Usuda et al. , "Peroxisomal and mitochondrial fatty acid β-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor and peroxisomal fatty acyl-CoA oxidase: Genotype correlation with fatty liver phenotype, " Journal of Biological Chemistry, vol. 274, no. 27, pp. 19228-19236, 1999.
40. Q. Su, C. Baker, P. Christian et al. , "Hepatic mitochondrial and ER stress induced by defective PPARα signaling in the pathogenesis of hepatic steatosis, " American Journal of Physiology. Endocrinology and Metabolism, vol. 306, no. 11, pp. E1264-E1273, 2014.
41. N. Dimopoulos, M. Watson, K. Sakamoto, and H. S. Hundal, "Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells, " Biochemical Journal, vol. 399, no. 3, pp. 473-481, 2006.
42. S. H. Koo, "Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis, " Clinical andMolecular Hepatology, vol. 19, pp. 210-215, 2013.
43. M. Nakamuta, M. Kohjima, S. Morizono et al. , "Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease, " International Journal of Molecular Medicine, vol. 16, no. 4, pp. 631-635, 2005.
44. S. Jitrapakdee, A. Wutthisathapornchai, J. C. Wallace, and M. J. MacDonald, "Regulation of insulin secretion: role of mitochondrial signalling, " Diabetologia, vol. 53, no. 6, pp. 1019-1032, 2010.
45. A. P. Rolo, J. S. Teodoro, and C. M. Palmeira, "Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis, " Free Radical Biology and Medicine, vol. 52, no. 1, pp. 59-69, 2012.
46. O. F. Sharifov, X. Xu, A. Gaggar et al. , "Anti-inflammatory mechanisms of apolipoprotein a-i mimetic peptide in acute respiratory distress syndrome secondary to sepsis, " PLoS ONE, vol. 8, Article ID e64486, 2013.
47. S. Huang, J. M. Rutkowsky, R. G. Snodgrass et al. , "Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways, " Journal of Lipid Research, vol. 53, no. 9, pp. 2002-2013, 2012.
48. Y. S. Roh and E. Seki, "Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis, " Journal of Gastroenterology and Hepatology, vol. 28, supplement 1, pp. 38-42, 2013.
49. T. le Roy, M. Llopis, P. Lepage et al. , "Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice, " Gut, vol. 62, no. 12, pp. 1787-1794, 2013.
50. R. Genolet, W. Wahli, and L. Michalik, "PPARs as drug targets to modulate inflammatory responses?" Current Drug Targets: Inflammation and Allergy, vol. 3, no. 4, pp. 361-375, 2004.
51. A. Tomizawa, Y. Hattori, T. Inoue, S. Hattori, and K. Kasai, "Fenofibrate suppressesmicrovascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation, " Metabolism: Clinical and Experimental, vol. 60, no. 4, pp. 513-522, 2011.